|
1
|
Matas AJ: Acute rejection is a major risk
factor for chronic rejection. Transplant Proc. 30:1766–1768. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gwinner W: Renal transplant rejection
markers. World J Urol. 25:445–455. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mihovilović K, Kardum-Skelin I, Ljubanović
D, Sabljar-Matovinović M, Vidas Z and Knotek M: Urine
immunocytology as a noninvasive diagnostic tool for acute kidney
rejection: a single center experience. Coll Antropol. 34:63–67.
2010.PubMed/NCBI
|
|
4
|
Hollander Z, Lin D, Chen V, et al: Whole
blood biomarkers of acute cardiac allograft rejection:
double-crossing the biopsy. Transplantation. 90:1388–1393. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viklicky O, Hribova P, Volk HD, et al:
Molecular phenotypes of acute rejection predict kidney graft
prognosis. J Am Soc Nephrol. 21:173–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fahmy NM, Yamani MH, Starling RC, et al:
Chemokine and chemokine receptor gene expression indicates acute
rejection of human cardiac transplants. Transplantation. 75:72–78.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Kaptanoglu L, Tang Y, et al:
IP-10-induced recruitment of CXCR3 host T cells is required for
small bowel allograft rejection. Gastroenterology. 126:809–818.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zerwes HG, Li J, Kovarik J, et al: The
chemokine receptor Cxcr3 is not essential for acute cardiac
allograft rejection in mice and rats. Am J Transplant. 8:1604–1613.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anders HJ, Vielhauer V and Schlöndorff D:
Chemokines and chemokine receptors are involved in the resolution
or progression of renal disease. Kidney Int. 63:401–415. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panzer U, Reinking RR, Steinmetz OM, et
al: CXCR3 and CCR5 positive T-cell recruitment in acute human renal
allograft rejection. Transplantation. 78:1341–1350. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanmaz T, Feng P, Torrealba J, et al:
Surveillance of acute rejection in baboon renal transplantation by
elevation of interferon-gamma inducible protein-10 and monokine
induced by interferon-gamma in urine. Transplantation.
78:1002–1007. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen X, Kudo T, Payne L, Wang X, Rodgers L
and Suzuki Y: Predominant interferon-γ-mediated expression of
CXCL9, CXCL10, and CCL5 proteins in the brain during chronic
infection with Toxoplasma gondii in BALB/c mice resistant to
development of toxoplasmic encephalitis. J Interferon Cytokine Res.
30:653–660. 2010.
|
|
13
|
McInnis KA, Britain A, Lausch RN and Oakes
JE: Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are
differentially regulated in human corneal keratocytes. Invest
Ophthalmol Vis Sci. 46:1668–1674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Campanella GS, Medoff BD, Manice LA,
Colvin RA and Luster AD: Development of a novel chemokine-mediated
in vivo T cell recruitment assay. J Immunol Methods. 331:127–139.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bromley SK, Mempel TR and Luster AD:
Orchestrating the orchestrators: chemokines in control of T cell
traffic. Nat Immunol. 9:970–980. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solez K, Colvin RB, Racusen LC, et al:
Banff ‘05 Meeting Report: differential diagnosis of chronic
allograft injury and elimination of chronic allograft nephropathy
(‘CAN’). Am J Transplant. 7:518–526. 2007.
|
|
17
|
Han Y, Guo H, Xu YJ, et al: Pathological
findings and clinical analyses on delayed renal graft function. SR
Essays. 6:4744–4748. 2011.
|
|
18
|
Xu X, Huang H, Cai M, et al: Serum
hematopoietic growth factors as diagnostic and prognostic markers
of acute renal allograft rejection: a potential role for serum stem
cell factor. Cytokine. 56:779–785. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen W, Pan X and Ni Z: Evaluation of 4
markers in the combining screening test for coronary heart disease.
Mod Prev Med. 33:723–724. 2006.
|
|
20
|
Guo WH, Tian L, Chan KL, Dallman M and Tam
PK: Role of CD4+ and CD8+ T cells in early
and late acute rejection of small bowel allograft. J Pediatr Surg.
36:352–356. 2001.
|
|
21
|
Campanella GS, Tager AM, El Khoury JK, et
al: Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are
required for the development of murine cerebral malaria. Proc Natl
Acad Sci USA. 105:4814–4819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Groom JR and Luster AD: CXCR3 in T cell
function. Exp Cell Res. 317:620–631. 2011. View Article : Google Scholar
|
|
23
|
Ranjbaran H, Wang Y, Manes TD, et al:
Heparin displaces interferon-gamma-inducible chemokines (IP-10,
I-TAC, and Mig) sequestered in the vasculature and inhibits the
transendothelial migration and arterial recruitment of T cells.
Circulation. 114:1293–1300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seung E, Cho JL, Sparwasser T, Medoff BD
and Luster AD: Inhibiting CXCR3-dependent CD8+ T cell
trafficking enhances tolerance induction in a mouse model of lung
rejection. J Immunol. 186:6830–6838. 2011.PubMed/NCBI
|
|
25
|
Christen U, McGavern DB, Luster AD, von
Herrath MG and Oldstone MB: Among CXCR3 chemokines, IFN-gamma-
inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but
not monokine induced by IFN-gamma (CXCL9) imprints a pattern for
the subsequent development of autoimmune disease. J Immunol.
171:6838–6845. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Menke J, Zeller GC, Kikawada E, et al:
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated
kidney disease. J Am Soc Nephrol. 19:1177–1189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thapa M, Welner RS, Pelayo R and Carr DJ:
CXCL9 and CXCL10 expression are critical for control of genital
herpes simplex virus type 2 infection through mobilization of
HSV-specific CTL and NK cells to the nervous system. J Immunol.
180:1098–1106. 2008. View Article : Google Scholar
|
|
28
|
Agostini C, Calabrese F, Rea F, et al:
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells
infiltrating lung allografts and mediate chemotaxis of T cells at
sites of rejection. Am J Pathol. 158:1703–1711. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Romagnani PL, Lazzeri E, Lasagni L, et al:
High expression of chemokines interferon-γ-inducible protein of 10
kDa (IP-10), monokine induced by interferon-γ-(Mig) and of their
receptor (CXCR3) in acute renal rejection. Am J Transplant.
1:S3432001.
|
|
30
|
Inston NG and Cockwell P: The evolving
role of chemokines and their receptors in acute allograft
rejection. Nephrol Dial Transplant. 17:1374–1379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Naidu BV, Krishnadasan B, Byrne K, et al:
Regulation of chemokine expression by cyclosporine A in alveolar
macrophages exposed to hypoxia and reoxygenation. Ann Thorac Surg.
74:899–905. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Xia J, Zhang K and Xu L: Suppression
of acute and chronic cardiac allograft rejection in mice by
inhibition of chemokine receptor 5 in combination with cyclosporine
A. J Surg Res. 157:81–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
